EBD Group is part of the Knowledge and Networking Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.
Founder and CEO at CureDuchenne
Debra Miller co-founded CureDuchenne in 2003 with her husband after their only son was diagnosed with Duchenne muscular dystrophy. Miller is a respected thought leader in venture philanthropy and medical advocacy. Miller also leads CureDuchenne Ventures LLC, a for-profit entity created to attract significant research funding to Duchenne research. She is a voice on various Duchenne review panels, such as the Department of Defense Duchenne Muscular Dystrophy Research Program and TREAT-NMD’s international review board TACT.Miller won Orange County Business Journal’s 2015 Women in Business Award and was a finalist for EY’s 2014 Entrepreneur of the Year in Orange County. Prior to CureDuchenne, Miller had a career in publishing with positions at IDG Communications, Cahners Publishing, Ziff-Davis Publishing and Scholastic Publishing. She also worked in management at PC Magazine and was an independent stock trader.Miller earned a Bachelor of Arts in Communication Studies from the University of California Los Angeles.